These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

704 related articles for article (PubMed ID: 31566079)

  • 1. Aquaporin-4-IgG positive neuromyelitis optica spectrum disorder and systemic autoimmune diseases overlap syndrome: a single-center experience.
    Martín-Nares E; Hernandez-Molina G; Fragoso-Loyo H
    Lupus; 2019 Oct; 28(11):1302-1311. PubMed ID: 31566079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overlap syndrome of anti-aquaporin 4 positive neuromyelitis optica spectrum disorder and primary Sjögren's syndrome: a systematic review of individual patient data.
    Prasad CB; Kopp CR; Naidu G; Sharma V; Misra DP; Agarwal V; Sharma A
    Rheumatol Int; 2024 Dec; 44(12):2807-2815. PubMed ID: 37500817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neuromyelitis optica spectrum disorders as initial presentation of Sjögren's syndrome: A case report].
    Alva Díaz C; Andamayo Villalba L; Mori N; Ventura Chilón JJ; Romero R
    Medwave; 2016 Feb; 16(1):e6388. PubMed ID: 26938585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aquaporin-4-autoimmunity in patients with systemic lupus erythematosus: A predominantly population-based study.
    Asgari N; Jarius S; Laustrup H; Skejoe HP; Lillevang ST; Weinshenker BG; Voss A
    Mult Scler; 2018 Mar; 24(3):331-339. PubMed ID: 28326889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Transverse myelitis syndrom as a result of neuromyelitis optica spectrum disorders, systemic lupus erythematosus and myasthenia gravis combination].
    Topuzova MP; Bisaga GN; Alekseeva TM; Isabekova PS; Сhaykovskaya AD; Panina EB; Pavlova TA; Ternovykh IK
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(7. Vyp. 2):97-106. PubMed ID: 32844638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presence of anti-Ro/SSA antibody may be associated with anti-aquaporin-4 antibody positivity in neuromyelitis optica spectrum disorder.
    Park JH; Hwang J; Min JH; Kim BJ; Kang ES; Lee KH
    J Neurol Sci; 2015 Jan; 348(1-2):132-5. PubMed ID: 25500159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuromyelitis optica and non organ-specific autoimmunity.
    Pittock SJ; Lennon VA; de Seze J; Vermersch P; Homburger HA; Wingerchuk DM; Lucchinetti CF; Zéphir H; Moder K; Weinshenker BG
    Arch Neurol; 2008 Jan; 65(1):78-83. PubMed ID: 18195142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders.
    Flanagan EP; Weinshenker BG; Krecke KN; Lennon VA; Lucchinetti CF; McKeon A; Wingerchuk DM; Shuster EA; Jiao Y; Horta ES; Pittock SJ
    JAMA Neurol; 2015 Jan; 72(1):81-7. PubMed ID: 25384099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients.
    Bouzar M; Daoudi S; Hattab S; Bouzar AA; Deiva K; Wildemann B; Reindl M; Jarius S
    J Neurol Sci; 2017 Oct; 381():240-244. PubMed ID: 28991690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overlap syndrome of anti-aquaporin-4 positive neuromyelitis optica spectrum disorder and systemic lupus erythematosus: A systematic review of individual patient data.
    Kopp CR; Prasad CB; Naidu S; Sharma V; Misra DP; Agarwal V; Sharma A
    Lupus; 2023 Sep; 32(10):1164-1172. PubMed ID: 37487596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuromyelitis optica in Portugal (NEMIPORT) - A multicentre study.
    Domingos J; Isidoro L; Figueiredo R; Brum M; Capela C; Barros P; Santos E; Macário Mdo C; Pinto Marques J; Pedrosa R; Vale J; Sá MJ
    Clin Neurol Neurosurg; 2015 Jul; 134():79-84. PubMed ID: 25965287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuromyelitis optica--complication or comorbidity in primary Sjögren's syndrome?
    Niţescu D; Nicolau A; Caraiola S; Predeţeanu D; Ionescu R; Tănăsescu C
    Rom J Intern Med; 2011; 49(4):295-300. PubMed ID: 22568275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Clinical Characteristics of Primary Sjogren's Syndrome With Neuromyelitis Optica Spectrum Disorder in China: A STROBE-Compliant Article.
    Qiao L; Wang Q; Fei Y; Zhang W; Xu Y; Zhang Y; Zhao Y; Zeng X; Zhang F
    Medicine (Baltimore); 2015 Jul; 94(28):e1145. PubMed ID: 26181553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency and syndrome specificity of antibodies to aquaporin-4 in neurological patients with rheumatic disorders.
    Jarius S; Jacobi C; de Seze J; Zephir H; Paul F; Franciotta D; Rommer P; Mader S; Kleiter I; Reindl M; Akman-Demir G; Seifert-Held T; Kristoferitsch W; Melms A; Wandinger KP; Wildemann B
    Mult Scler; 2011 Sep; 17(9):1067-73. PubMed ID: 21543553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuromyelitis optica spectrum disorder as an initial presentation of primary Sjögren's syndrome.
    Kahlenberg JM
    Semin Arthritis Rheum; 2011 Feb; 40(4):343-8. PubMed ID: 20655576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features of transverse myelitis associated with systemic lupus erythematosus.
    Zhang S; Wang Z; Zhao J; Wu DI; Li J; Wang Q; Su J; Xu D; Wang Y; Li M; Zeng X
    Lupus; 2020 Apr; 29(4):389-397. PubMed ID: 32054395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nationwide analysis of neuromyelitis optica in systemic lupus erythematosus and Sjogren's syndrome.
    Sami F; Sami SA; Manadan AM; Arora S
    Clin Rheumatol; 2024 Jan; 43(1):59-65. PubMed ID: 37980305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.
    Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Ringelstein M; Trebst C; Winkelmann A; Schwarz A; Buttmann M; Zimmermann H; Kuchling J; Franciotta D; Capobianco M; Siebert E; Lukas C; Korporal-Kuhnke M; Haas J; Fechner K; Brandt AU; Schanda K; Aktas O; Paul F; Reindl M; Wildemann B;
    J Neuroinflammation; 2016 Sep; 13(1):280. PubMed ID: 27793206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Semiquantitative measurement of aquaporin-4 antibodies as a possible surrogate marker of neuromyelitis optica spectrum disorders with systemic autoimmune diseases.
    Katsumata Y; Kawachi I; Kawaguchi Y; Gono T; Ichida H; Hara M; Yamanaka H
    Mod Rheumatol; 2012 Sep; 22(5):676-84. PubMed ID: 22183613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and incidence of neuromyelitis optica spectrum disorder, aquaporin-4 antibody-positive NMOSD and MOG antibody-positive disease in Oxfordshire, UK.
    O'Connell K; Hamilton-Shield A; Woodhall M; Messina S; Mariano R; Waters P; Ramdas S; Leite MI; Palace J
    J Neurol Neurosurg Psychiatry; 2020 Oct; 91(10):1126-1128. PubMed ID: 32576617
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 36.